# OnCo record nct06690775 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06690775/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06690775", "NCT06690775" ;
  schema:name "CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer."@en ;
  schema:alternateName "CATALINA-2"@en ;
  schema:description "A phase 2 trial of Pegfilgrastim in ovarian cancer, run by TORL Biotherapeutics, LLC, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06690775/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06690775> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2024-11-20" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/platinum-resistant-ovarian-cancer/> ;
  onco:technologies <https://onco.cc/technologies/g-csf-growth-factors/> ;
  onco:drugs <https://onco.cc/drugs/pegfilgrastim/> ;
  onco:companies <https://onco.cc/companies/torl-biotherapeutics/> .